Amphion Innovations plc,
Result of EGM

London and New York, 5 November 2007 - Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, announces that at the Extraordinary General Meeting today all resolutions were duly passed. Accordingly, the Company has issued and allotted 15,909,077 New Ordinary Shares of 1p each in the capital of the Company pursuant to the subscription and placing. It is expected that admission of the New Ordinary Shares to trading on AIM will become effective and dealings will commence on 6 November 2007.

For further information please contact

Amphion Innovations plc
Charlie Morgan, Director of Communications
+1 212 210 6224

Financial Dynamics
Ben Atwell
+44 20 7831 3113

Charles Stanley Securities
Mark Taylor / Freddy Crossley
+44 20 7149 6000

About Amphion Innovations plc
Amphion Innovations plc (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors. Amphion uses a focused, hands-on company building approach based on decades of experience in both the US and UK.

On the web: